Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer
Clinical trial NCT01270321 · COMPLETED
Trial details
- NCT number
- NCT01270321
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2019-02-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.